Kistler-Tiffany Companies’s Avanos Medical AVNS Stock Holding History

Kistler-Tiffany Companies’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-103	Closed	-$5K	–	567
2018 Q4	$5K	Hold	103	–	–	﹤0.01%	470
2018 Q3	$7K	Buy	+103	New	+$6.63K	﹤0.01%	458
2018 Q2	–	Sell	-103	Closed	-$5K	–	567
2018 Q1	$5K	Hold	103	–	–	﹤0.01%	491
2017 Q4	$5K	Hold	103	–	–	﹤0.01%	463
2017 Q3	$5K	Hold	103	–	–	﹤0.01%	448
2017 Q2	$4K	Sell	103 -220	-68%	-$8.31K	﹤0.01%	444
2017 Q1	$12K	Hold	323	–	–	0.01%	390
2016 Q4	$12K	Hold	323	–	–	0.01%	395
2016 Q3	$11K	Hold	323	–	–	0.01%	421
2016 Q2	$11K	Hold	323	–	–	0.01%	420
2016 Q1	$9K	Sell	323 -8	-2%	-$213	0.01%	424
2015 Q4	$11K	Buy	331 +8	+2%	+$249	0.01%	431
2015 Q3	$9K	Hold	323	–	–	0.01%	450
2015 Q2	$13K	Buy	+323	New	+$14.5K	0.01%	431
2015 Q1	–	Sell	-382	Closed	-$17K	–	583
2014 Q4	$17K	Buy	+382	New	+$15K	0.01%	386

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Kistler-Tiffany Companies's AVNS Position: Q1 2019 in Review

Kistler-Tiffany Companies sold out of Avanos Medical (AVNS) in Q1 2019, closing a stake of 103 shares — an estimated $5K sold.

Kistler-Tiffany Companies first reported a position in AVNS in Q4 2014 and held it in 15 quarters. The position peaked at $17K in Q4 2014. 338 funds tracked by Wall St. Rank hold AVNS as of Q1 2019.

Kistler-Tiffany Companies reported no remaining Avanos Medical position as of Q1 2019 after selling out during the quarter.
Kistler-Tiffany Companies sold 103 Avanos Medical shares in Q1 2019, an estimated $5K.
Kistler-Tiffany Companies first reported a position in Avanos Medical in Q4 2014 and held it in 15 quarters.
Kistler-Tiffany Companies's Avanos Medical position peaked at $17K in Q4 2014.
338 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2019.

Based on Kistler-Tiffany Companies's 13F filing for Q1 2019, filed 16 Apr 2019.